Induction of Antigen-Specific Tolerance by Targeting Disease Causing Antigens to Tolerogenic APCs

Time: 9:30 am
day: Conference Day Two


  • Targeting antigens to Antigen-Presenting Cell (APC) to direct tailor-made immune responses building on a well established cancer vaccine platform
  • Highlighting addition of immune-modulating proteins improves the effect
  • Demonstrating proof-of-concept in multiple models and across modalities